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Background: Although proven to be associated with bronchial obstruction, chest signs are not 
listed among cues that should prompt spirometry in the early diagnosis of chronic obstructive 
pulmonary disease (COPD) in established guidelines.
Aims: We aimed to explore how chest findings add to respiratory symptoms and a history of 
smoking in the diagnosis of COPD.
Methods: In a cross-sectional study, patients aged 40 years or older, previously diagnosed 
with either asthma or COPD in primary care, answered questionnaires and underwent physical 
chest examination and spirometry.
Results: Among the 375 patients included, 39.7% had forced expiratory volume in 1 second/
forced vital capacity ,0.7. Hyperresonance to percussion was the strongest predictor of COPD, 
with a sensitivity of 20.8, a specificity of 97.8, and likelihood ratio of 9.5. In multivariate 
logistic regression, where pack-years, shortness of breath, and chest findings were among the 
explanatory variables, three physical chest findings were independent predictors of COPD. 
Hyperresonance to percussion yielded the highest odds ratio (OR = 6.7), followed by diminished 
breath sounds (OR = 5.0), and thirdly wheezes (OR = 2.3). These three chest signs also gave 
significant diagnostic information when added to shortness of breath and pack-years in receiver 
operating-characteristic curve analysis.
Conclusion: We found that chest signs may add to respiratory symptoms and a history of 
smoking in the diagnosis of COPD, and we conclude that chest signs should be reinstated as 
cues to early diagnosis of COPD in patients 40 years or older.
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Introduction
Spirometry is the recommended method for assessing lung function in patients with 
suspected chronic obstructive pulmonary disease (COPD).1 Although spirometry 
testing is performed increasingly often and spirometers are about to become standard 
equipment at GPs’ offices in some countries, easy access does not apply to all. Also, 
lung-function assessment by spirometry testing is not only a question of availability. 
Even with a spirometer at hand, the GP has to select the right patients for this exami-
nation to be cost-effective.2
Spirometry screening has been proposed as a measure for early detection of COPD 
in smokers.3,4 The Global Initiative for Chronic Obstructive Lung Disease (GOLD) 
guidelines recommend a somewhat different approach, suggesting that COPD should 
be considered and spirometry performed if the patient is older than 40 years, and one 
or more of the following is present: dyspnea, chronic cough or sputum production, 





history of exposure to risk factors (eg, tobacco smoking), or 
a family history of COPD.1
Chest signs are not on this list of cues that should prompt 
spirometry in the early diagnosis of COPD, although several 
studies published between 1970 and 2002 have demon-
strated associations between chest findings and bronchial 
obstruction.5–11 This study aimed to clarify how chest signs 
are associated with bronchial obstruction and to what degree 
chest signs may add to respiratory symptoms and smoking 
history in the diagnosis of COPD.
Methods
subjects
Patients were recruited from seven GP offices in Norway. 
Of 43,241 patients listed at these offices, 18,931 were 
aged $40 years. Among these, 1,784 subjects had been reg-
istered with a diagnosis of asthma or COPD by a GP within 
5 years before the start of the study. A random sample of these 
(n = 1,111) were mailed an invitation to participate in our 
study, and 380 patients (34%) consented and were included. 
The patients were examined between April 2009 and March 
2010. The examinations, carried out by a total of 20 GPs dur-
ing a stable phase of the disease, included auscultation and 
percussion of the chest, questionnaires, and spirometry.12 The 
study was approved by the Regional Committee for Medical 
and Health Research Ethics.
Chest examination
Percussion and auscultation were performed bilaterally, and 
the GPs carried out the examinations as usual. The findings 
were recorded in a form integrated in the medical record that 
assured complete recordings. The form also included several 
items on the participants’ obstructive disease, comorbidity, 
and medications. Notably, the GPs were not told that the 
diagnostic usefulness of chest findings was among the objec-
tives of our study. Due to different practice routines, the chest 
examinations were carried out before spirometry in four of the 
GPs’ offices, and after spirometry in the remaining three.
Questionnaires
Each patient answered a clinical COPD questionnaire 
(CCQ),13 scoring their respiratory symptoms and limita-
tions in daily activities on scales from 0 to 6. Scores on 
shortness of breath, cough, and sputum were included as 
variables in the present study (Table 1). Smoking habits in 
terms of quantity and duration were recorded in a separate 
 questionnaire.  Pack-years (the number of cigarettes smoked 
daily multiplied by the number of total years of smoking, 
divided by 20) were calculated for each patient. Sporadic 
smokers were registered with 0.5 pack-years.
spirometry
Spirometry was carried out by trained health-care workers, who 
followed the guidelines of the European Respiratory Society/
American Thoracic Society.14 The patients were seated dur-
ing the examination, and did not wear a nose clip. They were 
told not to take their regular medications on the examination 
day. All offices used the Spirare SPS310 spirometer (Diag-
nostica, Oslo, Norway). Postbronchodilator spirometry was 
obtained 20 minutes after inhalation of 0.4 mg salbutamol. 
Norwegian reference values were applied.15
statistical analyses
The main outcome in the analysis was postbronchodilator 
forced expiratory volume in 1 second (FEV
1
)/forced vital 
capacity (FVC) , 0.7, which according to the GOLD criteria 
indicates a presence of COPD, although asthma may be the 
primary disease. A secondary outcome was postbronchodila-
tor FEV
1
% predicted ,50 in addition to FEV
1
/FVC , 0.7, 
indicating severe COPD (GOLD stage III–IV). The diag-
nostic properties of chest signs, symptoms, and pack-years 
with respect to COPD and severe COPD were evaluated 
by calculating sensitivity, specificity, predictive value, and 
likelihood ratio (LR). LRs with 95% confidence intervals 
were calculated using online software.16
Statistically significant predictors of COPD and severe 
COPD in bivariate analysis were entered into logistic regres-
sion models, with the two categories of reduced lung func-
tion as outcome variables. To account for clustering of data, 
Table 1 Questions on shortness of breath, cough, and phlegm in 
the clinical COPD questionnaire (CCQ)
On average, during the past week, how often did you feel: 
1. short of breath at rest? 
2. short of breath during physical activities?
In general, during the past week, how much of the time: 
5. Did you cough? 
6. Did you produce phlegm? 
One score (0–6) for each question
0 = never 
1 = hardly ever 
2 = a few times 
3 = several times
4 = Many times 
5 = a great many times 
6 = almost all the time
Abbreviation: COPD, chronic obstructive pulmonary disease.
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we used mixed-effect two-level models with the patient as 
first level and the examining GP as second level. A backward 
stepwise method was applied, in which only significant vari-
ables (P , 0.05) were retained in the final models.
Added diagnostic value of independent predictors in the 
multivariable logistic regression was evaluated by receiver 
operating-characteristic (ROC) curve analysis. A first curve 
was constructed by computing the sensitivity and specificity 
of the CCQ score of the significant respiratory symptom, 
a second curve by adding pack-years graded into five cat-
egories to the symptom score, and a third curve by adding 
the score for chest findings, reflecting the odds ratios of these 
findings, to the symptom score and the pack-year score. 
SPSS (version 19; IBM, Armonk, NY, USA) and STATA 
(version 12.0; College Station, TX, USA; two-level logistic 
regression) were used in the statistical analyses. A 5% level 
of statistical significance was applied.
sensitivity analyses
The GPs were not blinded for clinical information about 
the patients, and we checked whether chest examination 
after spirometry was associated with improved estimates 
of diagnostic value compared to chest examination before 
spirometry. Then we compared the sensitivity, specificity, 
and LRs of “any chest sign” obtained in practices where 
chest examination was carried out before spirometry with 
that obtained where chest examination was done after 
spirometry. In practices where chest examination was car-
ried out before spirometry, we also checked whether the 
diagnostic values of “any chest sign” differed dependent on 
whether the evaluation was done against prebronchodilator 
spirometry or postbronchodilator spirometry.
Results
Of the 380 patients who took part in the study, two were 
excluded from analysis due to ongoing exacerbation and 
three due to missing data. The mean (± standard deviation) 
age of the 375 included patients was 61.4 ± 11.5 years, 
and 61.9% were women; 74.4% were current or previous 
smokers, and 39.1% had smoked $20 pack-years (Table 2). 
Mild or moderate COPD (GOLD I–II) was registered in 
28.0%, and severe COPD (GOLD III–IV) in 11.7% of the 
subjects (Table 2). The most frequently reported respiratory 
symptoms were shortness of breath when doing physical 
activities and coughing (Table 2). At least one chest sign 
was recorded in 38.7% of the patients. Wheezes and dimin-
ished breath sounds were the chest signs most frequently 
Table 2 sex, age, diagnosis, smoking history, lung function 
(by gOlD stages), respiratory symptoms, and chest signs in 







,65 years 224 59.7
$65 years 151 40.3
Diagnosis by General Practitioner (GP)
Only COPD 74 19.7
Only asthma 210 56.0
Both COPD and asthma 91 24.3
Smoking history
never smoked 96 25.6
smoking now 106 28.3
Previously smoked 173 46.1
Pack-yearsa






normal spirometry/restriction 226 60.3
gOlD I 18 4.8
gOlD II 87 23.2
gOlD III or gOlD IV 44 11.7
Respiratory symptoms during the past week (from CCQ)
 short of breath at rest, several times or moreb 41 11.0
short of breath doing physical activities, 
several times or morec
191 51.5
short of breath doing physical activities, 
many times or mored
127 33.9
short of breath doing physical activities, 
a great many times or moree
69 18.6
Cough, several times or moref 149 40.3
Phlegm, several times or moreg 134 35.7
Chest signs
Wheezes/rhonchi
 Unilateral and/or bilateral 63 16.8
 Bilateral 53 14.1
Crackles
 Unilateral and/or bilateral 37 9.9
 Bilateral 26 6.9
 Diminished breath sounds
 Unilateral and/or bilateral 65 17.3
 Bilateral 54 14.4
Prolonged expiration 58 15.5
 hyperresonance to percussion
 Unilateral and/or bilateral 36 9.6
 Bilateral 33 8.8
Any of the five chest signs 145 38.7
Notes: an = 355, missing = 20; bmissing = 3; cmissing = 4; dmissing = 4; emissing = 4; 
fmissing = 5; gmissing = 6.
Abbreviations: gOlD, global Initiative for Chronic Obstructive lung Disease; 
COPD, chronic obstructive pulmonary disease; CCQ, clinical COPD questionnaire.





recorded (Table 2). The frequency of heavy smoking, 
severe dyspnea, and chest signs all increased significantly 
by decreasing lung function (P , 0.001 for all variables, 
Figure 1).
Diagnostic values
The probability of COPD increased by the number of pack-
years the patients had been smoking (Table 3). With more 
than 40 pack-years, the LR was 4.1. To have ever smoked had 
the highest sensitivity of all findings (0.83), but the specificity 
was low (0.35). Among the respiratory symptoms, shortness 
of breath doing physical activities, occurring a great many 
times the previous week, had the highest LR, whereas cough 
and phlegm were not significant predictors of COPD. The 
strongest COPD predictors were found among the chest signs, 
and hyperresonance to percussion had the highest LR (9.5) 
and specificity (0.98) (Table 3). There was no statistically 
significant association between crackles and COPD.
When the predictors were evaluated against severe 
COPD, sensitivity was generally higher and specificity lower, 
whereas the LRs were only slightly changed (Table 4).
Multivariate analysis
In the multivariate regression models, any degree of COPD 
could be independently predicted by pack-years but not by 
shortness of breath, whereas the opposite was the case for 
severe COPD (Table 5). Age and chest signs were significant 
predictors for both outcomes. Among the chest findings, 
diminished breath sounds and hyperresonance to percussion 
were the two strongest independent predictors.
ROC-curve analyses displaying diagnostic values 
for COPD of dyspnea score (CCQ score for shortness of 
breath during physical activities), pack-years, and chest-
finding score showed added diagnostic value when the 
three scores were used together (Figure 2). The added score 
predicted severe COPD more strongly (area under the curve 
[AUC] = 0.88) than it predicted COPD of any degree of 
severity (AUC = 0.75). The AUC obtained with all three 
scores in the model was higher than the upper limit of the 
95% confidence interval of the AUC when only pack-years 
and dyspnea score were included.
sensitivity analyses
COPD was somewhat more prevalent and chest signs less 
frequently recorded in the four practices where auscultation 
was done before spirometry, compared to the other three 
practices (Table 6). The less frequent recording of abnormal 
chest findings was associated with somewhat lower sensitiv-
ity and considerably higher specificity and LR. This was the 
case whether the diagnostic value of any chest finding was 




Presence of prolonged expiration, wheezes, hyperresonance 
to percussion, and diminished breath sounds by physical 
chest examination significantly increased the probability of 
bronchial obstruction in our study sample. Hyperresonance 
to percussion and diminished breath sounds got higher like-
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Figure 1 Frequency of heavy smoking, shortness of breath, and chest findings by level of lung function in 375 patients aged $40 years diagnosed with asthma or chronic 
obstructive pulmonary disease (COPD) in primary care. The patients were in a stable phase of illness.
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Table 3 Values of smoking habit, respiratory symptoms, and chest signs in predicting COPD (postbronchodilator FeV1/FVC , 0.7) in 
375 patients diagnosed with asthma or COPD
Sensitivity Specificity LR CI PPV (%)
smoking
 .0 pack-years 0.87 0.34 1.3 1.2–1.5 46.6
 $20 pack-years 0.61 0.76 2.5 1.9–3.3 62.6
 $40 pack-years 0.19 0.95 4.1 2.0–8.2 73.0
respiratory symptoms during the previous week
 short of breath at rest, several times or more 0.13 0.90 1.3 0.8–2.4 46.3
  short of breath doing physical activities,  
several times or more
0.63 0.57 1.4 1.2–1.8 48.7
  short of breath doing physical activities,  
many times or more
0.42 0.71 1.4 1.1–1.9 48.0
  short of breath doing physical activities,  
a great many times or more
0.27 0.87 2.0 1.3–3.0 56.5
 Cough, several times or more 0.40 0.60 1.0 0.8–1.3 39.6
 Phlegm, several times or more 0.36 0.63 1.0 0.7–1.3 38.8
Chest signs
 Wheezes/rhonchi 0.26 0.89 2.3 1.5–3.7 60.3
 Crackles 0.09 0.90 0.9 0.5–1.8 37.8
 Diminished breath sounds 0.34 0.93 5.1 3.0–8.7 76.9
 Prolonged expiration 0.29 0.93 4.3 2.5–7.5 74.1
 hyperresonance to percussion 0.21 0.98 9.5 3.7–23.7 86.1
 Any of the five chest signs 0.58 0.74 2.3 1.8–3.0 60.0
Note: The overall prevalence of COPD was 39.7%.
Abbreviations: COPD, chronic obstructive pulmonary disease; FeV1, forced expiratory volume in 1 second; FVC, forced vital capacity; lr, likelihood ratio; 
CI, confidence interval; PPV, positive predictive value.
Table 4 Diagnostic values of smoking habit, respiratory symptoms, and chest signs in predicting severe COPD (postbronchodilator 
FeV1/FVC , 0.7 and FeV1% predicted ,50) in 375 patients diagnosed with asthma or COPD
Sensitivity Specificity LR CI PPV (%)
smoking
 .0 pack-years 0.96 0.28 1.3 1.2–1.5 15.1
 $20 pack-years 0.72 0.65 2.1 1.6–2.7 22.3
 $40 pack-years 0.30 0.92 3.9 2.2–7.1 35.1
respiratory symptoms during the previous week
  short of breath at rest, several times 
or more
0.23 0.91 2.4 1.3–4.6 24.4
  short of breath doing physical activities, 
several times or more
0.89 0.54 1.9 1.6–2.2 20.4
  short of breath doing physical activities, 
many times or more
0.64 0.70 2.1 1.6–2.8 22.0
  short of breath doing physical activities, 
a great many times or more
0.41 0.84 2.6 1.7–4.1 21.6
 Cough, several times or more 0.52 0.61 1.6 0.9–2.9 15.4
 Phlegm, several times or more 0.46 0.65 1.3 0.9–1.9 14.9
Chest findings
 Wheezes/rhonchi 0.36 0.86 2.7 1.6–4.1 25.4
 Crackles 0.09 0.90 0.9 0.3–2.5 10.8
 Diminished breath sounds 0.57 0.88 4.7 3.2–6.9 38.5
 Prolonged expiration 0.43 0.88 3.7 2.3–5.7 32.8
 hyperresonance to percussion 0.39 0.94 6.7 3.8–12.0 47.2
 Any of the five chest signs 0.82 0.67 2.5 2.0–3.1 24.8
Note: The overall prevalence of severe COPD was 11.7%.
Abbreviations: COPD, chronic obstructive pulmonary disease; FeV1, forced expiratory volume in 1 second; FVC, forced vital capacity; LR, likelihood ratio; CI, confidence 
interval (for lr); PPV, positive predictive value.





lihood ratios than did heavy smoking and any respiratory 
symptoms. These two chest signs, and also wheezes, were 
found with similar frequency in the patients with moderate 
COPD (GOLD II), as were $40 pack-years and frequent 
dyspnea on physical activities. The three chest signs gave 
significant diagnostic information when added to dyspnea 
and pack-years, as shown by both logistic regression and 
ROC-curve analysis. A model including pack-years, short-
ness of breath, and chest signs had good test characteristics 
by ROC-curve analysis in predicting COPD and even better in 
predicting severe COPD. The findings indicate that abnormal 
chest findings, as well as a history of shortness of breath and 
smoking, are cues that should prompt spirometry in patients 
40 years or older with no established diagnosis of COPD.
strengths and weaknesses
Our study is among the largest studies carried out to evalu-
ate chest findings as signs of bronchial obstruction. For 
comparison of our results with previous studies, it was an 
advantage to evaluate against both “any” COPD and severe 
COPD, since reductions in lung function somewhere in 
between our two cutoff levels have usually been used as 
outcomes in previous studies. Although the sensitivity of the 
chest findings was higher and specificity lower when using 
severe obstruction as the reference standard compared to 
when FEV
1
/FVC , 0.7 was used, we observed that the LR 
showed little variation (Tables 3 and 4), as can be expected 
when both the numerator and the denominator in the frac-
tion (sensitivity/1 - specificity) decreases. This supports 
comparisons with previous studies.
A main concern in studies like this is the selection of 
patients studied and whether the results are applicable in other 
settings. Like in most previous studies, our study sample 
consisted of patients with known or possible obstructive lung 
disease. The patients had at least once during the preceding 
5 years been labeled with a diagnosis of asthma or COPD, 
but we do not know to what degree the registered diagnoses 
were based on established criteria.12 Overrepresentation of 
severe cases among the COPD patients and overrepresenta-
tion of asthma among those with normal spirometry have 
most probably led to increased sensitivity and decreased 
specificity of the chest signs. The LRs, however, were prob-
ably less affected. Ideally, we should have recruited unse-
lected patients above 40 years of age. Only a few studies have 
focused on adults without known bronchial obstruction.11,17,18 
Table 6 Sensitivity analysis comparing lung function, the prevalence of any chest sign, and the sensitivity, specificity, and likelihood ratio 
of any chest sign for COPD in practices where patients were examined before spirometry and after spirometry
n Any chest  
sign, n (%)
COPD (FEV1/ 
FVC , 0.7), n (%)
Sensitivity Specificity Likelihood ratio 
(95% CI)
Patients examined before spirometry  
(4 GP offices)
  evaluated against  
prebronchodilator spirometry
211 72 34.1a 98 46.4b 53.1 82.3 3.0 (1.9–4.7)
  evaluated against  
postbronchodilator spirometry
211 72 34.1 94 44.5c 56.7 83.8 3.5 (2.2–5.4)
Patients examined after  
spirometry (3 GP offices)
164 73 44.5 55 33.5 61.8 64.2 1.7 (1.2–2.4)
Notes: aThe difference between the subgroups examined before and after spirometry was statistically significant, P = 0.04; bthe difference between the subgroups examined 
before and after spirometry was statistically significant, P = 0.01; cthe difference between the subgroups examined before and after spirometry was statistically significant, P = 0.03. 
Abbreviations: COPD, chronic obstructive pulmonary disease; FeV1, forced expiratory volume in 1 second; FVC, forced vital capacity; CI, confidence interval; GP, General 
Practitioner.
Table 5 Independent predictive values of smoking, respiratory 
symptoms, and chest signs for COPD (FeV1/FVC , 0.7) and 
severe COPD (FeV1/FVC , 0.7 and FeV1% predicted ,50), 
as evaluated by multivariate logistic regression in 351 patients 







Male sex 1.8 1.1–3.2 ns
age 2.7 1.6–4.7 2.4 1.1–5.1
Pack years
 $20–40 4.9 2.7–8.8 ns
 $40 3.3 1.3–8.3 ns
short of breath doing physical activities the previous week
 several times ns 1.7 1.1–2.5
 Many times ns 1.5 1.1–2.0
 a great many times ns 8.4 2.7–25.8
Chest signs
 Wheezes/rhonchi 2.3 1.1–4.8 ns
  Diminished breath  
sounds
5.0 2.2–11.3 4.4 2.0–9.8
  hyperresonance  
to percussion
6.7 2.0–22.0 5.3 2.0–13.7
Abbreviations: COPD, chronic obstructive pulmonary disease; FeV1, forced 
expiratory volume in 1 second; FVC, forced vital capacity; CI, confidence interval; 
NS, not significant.
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There is a tendency of decreasing frequency of chest signs 
in COPD patients (sensitivity) with decreasing prevalence 
of COPD in the study sample. The lower sensitivity in such 
samples is usually counterweighted by a higher specificity,11 
resulting in the LR being less affected.17 This makes it likely 
that our results are applicable also in patient populations with 
a lower prevalence of COPD.
The computerized form the GPs had to fill in during the con-
sultation led to complete recording of chest findings. Since all 
patients had previously been labeled with a diagnosis of asthma 
or COPD by a GP, one could expect that the chest examination 
was carried out with similar attention in all patients. However, 
chest findings only made up a small part of the registrations, 
and the main topic of the study was exacerbations of asthma 
and COPD. With this focus, the GPs have probably been less 
prone to “adjust” their recordings to the severity of the patient’s 
disease than if evaluation of chest examination had been the 
aim. A rigorous design with the GPs blinded for all clinical 
information was probably not of fundamental importance. At 
the three GP practices where chest examination was carried 
out after the spirometry, the GPs could in theory check the 
spirogram before examining the patient and possibly expect 
more chest findings in patients with bronchial obstruction and 
fewer findings when the FEV
1
/FVC was above 0.7. From the 
results, this does not appear to have occurred. More findings 
were recorded in patients without obstruction, and the lowest 
specificity and LRs of chest findings were found in the practices 
where the patients were examined after spirometry.
This inconsistency suggests sources of flaw that cannot be 


























Predicting COPD (FEV1/FVC < 0.7)




Short of breath doing physical
activities
AUC = 0.74 [95% CI 0.68–0.81]
Short of breath doing physical
activities + packyears
AUC = 0.80 [95% CI 0.73–0.87]
Short of breath doing physical
activities + packyears + chest
finding score
AUC = 0.88 [95% CI 0.83–0.93]
Reference line
Short of breath doing physical
activities
AUC = 0.62 [95% CI 0.57–0.68]
Short of breath doing physical
activities + packyears
AUC = 0.70 [95% CI 0.64–0.75]
Short of breath doing physical
activities + packyears + chest
finding score
AUC = 0.75 [95% CI 0.70–0.80]
Reference line
Figure 2 receiver operating-characteristic curves showing predictive value of three different scores in predicting COPD (FeV1/FVC , 0.7) and severe COPD (FeV1/
FVC , 0.7 and FeV1% predicted ,50): dyspnea score (short of breath doing physical activities in the clinical COPD questionnaire), summing up of dyspnea score and pack-
years (0–10, 1; 10–20, 2; 20–40, 3; $40, 4), and summing up of dyspnea score, pack-years, and chest-finding score (addition of wheezes, 1; diminished breath sound, 2; 
hyperresonance to percussion, 3).
Abbreviations: COPD, chronic obstructive pulmonary disease; FeV1, forced expiratory volume in 1 second; FVC, forced vital capacity; CI, confidence interval; AUC, area 
under the curve.





have demonstrated considerable interobserver  variation when 
patients have been examined by more than one doctor.19 
This has particularly been the case for hyperresonance to 
percussion and diminished breath sounds.19 Percussion of 
the chest is somewhat demanding, and the skills needed to 
elicit a hyperresonant sound may vary between doctors.20 To 
differentiate between normal and diminished breath sounds, 
proper instructions to the patient, clinical experience, and 
attentive listening are needed. The terms used for abnormal 
lung sound vary between clinicians.21,22 Improved skills 
among the GPs in examining the chest and more standard-
ized use of terms when describing the findings are likely to 
improve the diagnostic value of the findings.
The most important strength of the study is that we 
evaluated chest signs together with smoking history and 
shortness of breath, the symptoms regarded as the best cues 
to an early diagnosis of COPD. We found chest signs to be 
independent predictors that add to these established cues, 
and we see no good reason why these strong findings should 
not be applicable also in unselected adults, at least to some 
significant degree.
Comparisons with previous studies
hyperresonance to percussion
Similar sensitivity and specificity of hyperresonance to 
percussion have been found in previous studies when 
evaluated against bronchial obstruction among adults with 
a possible lung disease11 or a history of smoking.6 Our study 
confirms that hyperresonance to percussion is a strong 
predictor, with an LR above 5.
Diminished breath sounds
Diminished breath sounds have also previously been shown 
to predict bronchial obstruction, with LRs between 2 and 6.11 
In a recent study from primary care of patients with persis-
tent cough, diminished breath sounds significantly predicted 
FEV
1
/FVC , 0.7 in univariate analysis (sensitivity 0.16 
and specificity 0.91), but not in multivariate analysis.18 The 
considerable variation in diagnostic properties of this vari-
able probably reflects that it is particularly susceptible to 
interobserver variability.
Wheezes/rhonchi and crackles
Associations between wheezes/rhonchi and bronchial obstruc-
tion have been demonstrated in several studies,9,10,17,18,23,24 and 
LRs between 2 and 3, as in the present study, have been found, 
also among patients without known bronchial obstruction.11,17,18 
Crackles were not a significant predictor in our study, in con-
trast to what has been found in previous studies.7,11
smoking and respiratory symptoms
Smoking history, shortness of breath, and cough with phlegm 
are well-known predictors of COPD.17,24–27 In a recent study 
of adults aged 40 years or more with a COPD prevalence 
of only 9.6%, all these variables were significant predictors 
of COPD.28 The ROC-curve analysis of a diagnostic model 
including age, smoking status, and breathlessness obtained 
an AUC of 0.77.28 This is close to the AUC of 0.80 for pack-
years and dyspnea when evaluated against severe COPD in 
our study.
Implications for practice
Based on our findings and supported by previous studies, we 
suggest reinstating chest findings as cues to the early diag-
nosis of COPD. At present, their relevance is not reflected in 
established guidelines. Smoking and respiratory symptoms, 
but not chest findings, are listed as information that should 
lead to spirometry in a search for COPD. GOLD argues that 
“Physical signs of airflow limitation are usually not present until 
significant impairment of lung function has occurred, and their 
detection has a relatively low sensitivity and specificity.”1 In the 
National Institute for Health and Care Excellence guidelines, it 
is stated that the diagnosis of COPD “is suspected on the basis 
of symptoms and signs and supported by spirometry.” Physi-
cal chest findings are not listed among the clinical information 
that should raise suspicion for COPD, and are considered less 
predictive than symptoms in COPD assessment.29 A similar 
understanding of the value of chest signs in the early diagnosis 
of COPD is presented by Rennard.30
The predictive value of chest signs for COPD is only one 
reason chest findings should be reinstated in early diagnosis. 
In practice, chest examination is carried out in all kinds of 
patients, such as those with hypertension, heart disease, and 
respiratory tract infections. The examination is done quickly 
and carried out frequently, also during busy consultations, 
and it has high standing (face value) among patients. To elicit 
a thorough history on smoking and respiratory symptoms, 
which of course often should be done, takes longer time and 
is probably less frequently carried out. COPD questionnaires 
are not easily implemented in a busy practice, and they have 
not been evaluated as elements of ordinary consultations. 
So far, we do not know whether the diagnostic properties of 
such questionnaires in disclosing mild-to-moderate COPD 
are better than those of chest signs.
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